CHU Mont-Godinne
Also known as: Centre Hospitalier Universitaire Dinant Godinne | Centre Hospitalier Universitaire Dinant Godinne - UCL Namur | CHU Dinant Godinne, UCL Namur, Yvoir - Belgium - LYSA | CHU-UCL Mont-Godinne | Cliiques Universitaire Mont-Godinne, Yvoir | Cliniques Universitaires de Mont-Godinne | Cliniques Universitaires Mont-Godinne | Cliniques Universitaires, Mont Godinne | Cliniques Universitaires Mont-Godinne at Yvoir | Cliniques Universitaires UCL de Mont-Godinne, Dr Joseph Kerger | Cliniques Universitaires UCL Mont Godinne, Belgium | Clinqiue Universitaire de Mont Godinne | University Hospital of Mont-Godinne
Highest phase reached
Phase 4
First clinical trial
Dec 1, 2003Last known activity
Apr 23, 2019
Timeline
1970s
- Jul 1, 1976
CHU Mont-Godinne— Founded
Drugs by trial phase (23 distinct, 15 trials)
Phase 4 (5 own, 0 via acquisition)
Phase 3 (4 own, 0 via acquisition)
Phase 2 (13 own, 0 via acquisition)
Other trials (1 own, 0 via acquisition)
Indications
Studied for
- Asthma
- Bone Diseases, Metabolic
- Carcinoma
- Carcinoma, Hepatocellular
- Carcinoma, Squamous Cell
- Disease
- Epilepsy
- Graft vs Host Disease
- Hodgkin Disease
- Leukemia
- Leukemia, Lymphocytic, Chronic, B-Cell
- Leukemia, Lymphoid
- Leukemia, Myelogenous, Chronic, BCR-ABL Positive
- Leukemia, Myeloid
- Leukemia, Myeloid, Acute
- Liver Neoplasms
- Lung Diseases
- Lung Diseases, Obstructive
- Lymphoma
- Lymphoma, Non-Hodgkin
- Lymphoma, T-Cell
- Lymphoma, T-Cell, Peripheral
- Multiple Myeloma
- Muscle Spasticity
- Myelodysplastic Syndromes
- Myeloproliferative Disorders
- Precursor Cell Lymphoblastic Leukemia-Lymphoma
- Preleukemia
- Prostatic Neoplasms
- Pulmonary Disease, Chronic Obstructive
- Recurrence
- Stroke
- Syndrome
Recent trials (23)
- NCT03910985Lead sponsorPhase 4Apr 23, 2019
- NCT03910985Reponsible party - principal investigatorPhase 4Apr 23, 2019
- NCT03580408Study chairPhase 2Aug 31, 2018
- NCT03476109CollaboratorPhase 4Mar 30, 2018
- NCT02958163CollaboratorPhase 2Feb 20, 2017
- NCT02114736Reponsible party - principal investigatorPhase 4Mar 1, 2014
- NCT02114736Lead sponsorPhase 4Mar 1, 2014
- NCT02032082Lead sponsorN/AJan 31, 2014
- NCT02032082Reponsible party - principal investigatorN/AJan 31, 2014
- NCT02017457Sponsor investigatorPhase 2Dec 1, 2013
- NCT02017457Overall official - principal investigatorPhase 2Dec 1, 2013
- NCT01823159Overall official - principal investigatorPhase 3Apr 1, 2013
- NCT01823159Reponsible party - principal investigatorPhase 3Apr 1, 2013
- NCT01823159Lead sponsorPhase 3Apr 1, 2013
- NCT01428973CollaboratorPhase 2Sep 1, 2011
Details
- Founded
- Brussels, BE Jul 1, 1976
- Last known activity
- Apr 23, 2019
Notes
--- Pre-folding founded info: None None None None None ---